1979
DOI: 10.1530/jrf.0.0560627
|View full text |Cite
|
Sign up to set email alerts
|

Further investigation of the antiovulatory effects of the antiprogestational steroid RMI 12,936 in the rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1979
1979
1981
1981

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…Since no entirely specific agents of this type are available two steroids with different mechanisms of antiprogestational activity and different spectra of other biological activities were used. RMI 12,936 (17ß-hydroxy-7a methyl androst-5-en-3-one) is an antiprogestational steroid with weak oestrogenic, antioestrogenic and androgenic activities; it inhibits progesterone secretion and may be metabolized to a further compound which antagonizes the effects of progesterone (Kendle, 1975(Kendle, , 1976(Kendle, , 1978Grunwell, Benson, Johnston & Petrow, 1976;Geddes, Kendle, Shanks & Steven, 1979). R2323 (13-ethyl-17-hydroxy-18,19-dinor-17a-pregna-4,9,ll-trien-20-yn-3-one) has weak oestrogenic, weak andro¬ genic and antioestrogenic activities and is a competitive antagonist of progesterone (Sakiz & Azadian-Boulanger, 1971;Sakiz, Azadian-Boulanger & Raynaud, 1974;Raynaud et al, 1975).…”
Section: Introductionmentioning
confidence: 99%
“…Since no entirely specific agents of this type are available two steroids with different mechanisms of antiprogestational activity and different spectra of other biological activities were used. RMI 12,936 (17ß-hydroxy-7a methyl androst-5-en-3-one) is an antiprogestational steroid with weak oestrogenic, antioestrogenic and androgenic activities; it inhibits progesterone secretion and may be metabolized to a further compound which antagonizes the effects of progesterone (Kendle, 1975(Kendle, , 1976(Kendle, , 1978Grunwell, Benson, Johnston & Petrow, 1976;Geddes, Kendle, Shanks & Steven, 1979). R2323 (13-ethyl-17-hydroxy-18,19-dinor-17a-pregna-4,9,ll-trien-20-yn-3-one) has weak oestrogenic, weak andro¬ genic and antioestrogenic activities and is a competitive antagonist of progesterone (Sakiz & Azadian-Boulanger, 1971;Sakiz, Azadian-Boulanger & Raynaud, 1974;Raynaud et al, 1975).…”
Section: Introductionmentioning
confidence: 99%